EGA
TARO
Eagle Global Advisors’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-6,500
| Closed | -$555K | – | 222 |
|
|
2019
Q2 | $555K | Hold |
6,500
| – | – | 0.02% | 164 |
|
|
2019
Q1 | $703K | Buy |
+6,500
| New | +$703K | 0.03% | 157 |
|
|
2018
Q4 | – | Sell |
-2,200
| Closed | -$216K | – | 249 |
|
|
2018
Q3 | $216K | Buy |
+2,200
| New | +$216K | 0.01% | 220 |
|
|
2018
Q1 | – | Sell |
-5,500
| Closed | -$576K | – | 258 |
|
|
2017
Q4 | $576K | Hold |
5,500
| – | – | 0.02% | 175 |
|
|
2017
Q3 | $620K | Hold |
5,500
| – | – | 0.02% | 169 |
|
|
2017
Q2 | $616K | Buy |
+5,500
| New | +$616K | 0.02% | 197 |
|
|
2016
Q3 | – | Sell |
-2,600
| Closed | -$379K | – | 390 |
|
|
2016
Q2 | $379K | Hold |
2,600
| – | – | 0.01% | 230 |
|
|
2016
Q1 | $372K | Hold |
2,600
| – | – | 0.01% | 239 |
|
|
2015
Q4 | $402K | Hold |
2,600
| – | – | 0.01% | 234 |
|
|
2015
Q3 | $372K | Sell |
2,600
-500
| -16% | -$71.5K | 0.01% | 242 |
|
|
2015
Q2 | $445K | Hold |
3,100
| – | – | 0.01% | 233 |
|
|
2015
Q1 | $437K | Hold |
3,100
| – | – | 0.01% | 210 |
|
|
2014
Q4 | $459K | Hold |
3,100
| – | – | 0.01% | 207 |
|
|
2014
Q3 | $477K | Hold |
3,100
| – | – | 0.01% | 188 |
|
|
2014
Q2 | $435K | Buy |
+3,100
| New | +$435K | 0.01% | 182 |
|